These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35252267)

  • 61. Association between pachychoroid and long-term treatment outcomes of photodynamic therapy with intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Azuma K; Okubo A; Nomura Y; Zhou H; Terao R; Hashimoto Y; Asano KS; Azuma K; Inoue T; Obata R
    Sci Rep; 2020 May; 10(1):8337. PubMed ID: 32433551
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis.
    Miura M; Iwasaki T; Goto H
    Clin Ophthalmol; 2013; 7():1591-5. PubMed ID: 23966764
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Short-term focal macular electroretinogram of eyes treated by aflibercept & photodynamic therapy for polypoidal choroidal vasculopathy.
    Takayama K; Kaneko H; Kataoka K; Ueno S; Chang-Hua P; Ito Y; Terasaki H
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):449-455. PubMed ID: 27538907
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effectiveness and Safety of Intravitreal Injection of Conbercept as an Initial Treatment for Exudative Circumscribed Choroidal Hemangioma.
    Lai K; Gong Y; Xu F; Li L; Huang C; Zhou L; Zhong X; Yang H; Lu L; Jin C
    Ophthalmologica; 2020; 243(6):436-443. PubMed ID: 31905362
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of Efficacy of Intravitreal Ranibizumab and Aflibercept in Eyes with Myopic Choroidal Neovascularization: 24-Month Follow-Up.
    Korol A; Kustryn T; Zadorozhnyy O; Pasyechnikova N; Kozak I
    J Ocul Pharmacol Ther; 2020 Mar; 36(2):122-125. PubMed ID: 31755809
    [No Abstract]   [Full Text] [Related]  

  • 66. One-year outcomes of novel VEGF decoy receptor therapy with intravitreal conbercept in diabetic retinopathy-induced macular edema.
    Zhou Q; Guo C; You A; Wang D; Wang W; Zhang X
    Mol Vis; 2019; 25():636-644. PubMed ID: 31700228
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of aflibercept in patients with age-related macular degeneration.
    Okuma H; Mimura T; Goto M; Kamei Y; Yoshida M; Kondo A; Matsubara M
    Int Ophthalmol; 2016 Apr; 36(2):159-69. PubMed ID: 26043678
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of intravitreal aflibercept injections for Japanese patients with polypoidal choroidal vasculopathy.
    Arakawa A; Inoue M; Sato S; Yamane S; Kadonosono K
    Clin Ophthalmol; 2017; 11():797-802. PubMed ID: 28490861
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term prognosis of polypoidal choroidal vasculopathy with a 5-year remission after an initial combination therapy.
    Kikushima W; Sakurada Y; Yoneyama S; Sugiyama A; Matsubara M; Fukuda Y; Kashiwagi K
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102453. PubMed ID: 34303031
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ONE-YEAR RESULTS OF INTRAVITREAL AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Hara C; Sawa M; Sayanagi K; Nishida K
    Retina; 2016 Jan; 36(1):37-45. PubMed ID: 26383709
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of intravitreal bevacizumab to photodynamic therapy for polypoidal choroidal vasculopathy: short-term results.
    Mitamura Y; Kitahashi M; Kubota-Taniai M; Yamamoto S
    Indian J Ophthalmol; 2010; 58(4):291-6. PubMed ID: 20534918
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Initial treatment for polypoidal choroidal vasculopathy: Ranibizumab combined with photodynamic therapy or fixed-dosing aflibercept monotherapy.
    Yoneda A; Wakiyama H; Kurihara J; Kitaoka T
    Eur J Ophthalmol; 2020 Nov; 30(6):1473-1479. PubMed ID: 31476891
    [TBL] [Abstract][Full Text] [Related]  

  • 73. One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Sakurai M; Baba T; Kitahashi M; Yokouchi H; Kubota-Taniai M; Bikbova G; Oshitari T; Yamamoto S
    Clin Ophthalmol; 2014; 8():235-41. PubMed ID: 24511222
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combined photodynamic therapy with intravitreal bevacizumab injections for polypoidal choroidal vasculopathy: long-term visual outcome.
    Kang HM; Koh HJ; Lee CS; Lee SC
    Am J Ophthalmol; 2014 Mar; 157(3):598-606.e1. PubMed ID: 24269378
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor.
    Moon DRC; Lee DK; Kim SH; You YS; Kwon OW
    Korean J Ophthalmol; 2015 Aug; 29(4):226-32. PubMed ID: 26240506
    [TBL] [Abstract][Full Text] [Related]  

  • 76. EFFICACY OF INTRAVITREAL INJECTION OF CONBERCEPT IN POLYPOIDAL CHOROIDAL VASCULOPATHY: Subgroup Analysis of the Aurora Study.
    Qu J; Cheng Y; Li X; Yu L; Ke X;
    Retina; 2016 May; 36(5):926-37. PubMed ID: 26595362
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Photodynamic therapy combined with intravitreal injection of vascular endothelial growth factor antibody for polypoidal choroidal vasculopathy.
    Moon SW; Kim MS; Kim ES; Yu SY; Kwak HW
    Ophthalmologica; 2011; 225(3):169-75. PubMed ID: 21273795
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reduced-fluence photodynamic therapy combined with intravitreal bevacizumab for polypoidal choroidal vasculopathy.
    Sagong M; Lim S; Chang W
    Am J Ophthalmol; 2012 May; 153(5):873-882.e2. PubMed ID: 22265146
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intravitreal bevacizumab and ranibizumab injections for patients with polypoidal choroidal vasculopathy.
    Cho HJ; Kim JW; Lee DW; Cho SW; Kim CG
    Eye (Lond); 2012 Mar; 26(3):426-33. PubMed ID: 22173075
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Optic disk melanocytoma associated with polypoidal choroidal vasculopathy lesions, after combination treatment of photodynamic therapy and intavitreal aflibercept (Eylea), a case report.
    Rouvas A; Gouliopoulos NS; Moschos MM; Theodossiadis P
    BMC Ophthalmol; 2018 Oct; 18(1):267. PubMed ID: 30309335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.